Chimo, a smokeless tobacco preparation, is associated with a higher frequency of type 2 diabetes.

  • Juan P. González-Rivas The Andes Clinic of Cardio-Metabolic Studies, Mérida, Venezuela.
  • Ramfis Nieto-Martínez University Centro-Occidental “Lisandro Alvarado” and Cardio-metabolic Unit 7, Barquisimeto, Venezuela.
  • Raúl García Santiago The Andes Diagnostic Center, San Cristóbal, Venezuela
  • Eunice Ugel University Centro-Occidental “Lisandro Alvarado” and Cardio-metabolic Unit 7, Barquisimeto, Venezuela.
  • Jeffrey I. Mechanick Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Abstract

Ver Resumen PDF.

Downloads

Download data is not yet available.
Published
2017-10-06
How to Cite
González-Rivas, J. P., Nieto-Martínez, R., García Santiago, R., Ugel, E., & Mechanick, J. I. (2017). Chimo, a smokeless tobacco preparation, is associated with a higher frequency of type 2 diabetes. Investigación Clínica, 58(3), 250 - 258. Retrieved from https://produccioncientificaluz.org./index.php/investigacion/article/view/29061
Issue
Vol. 58 No. 3
Section
Original Works